Teri E. Klein
Impact in
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism
- Transplantation top 0.5%
Papers in
- Pharmacology 115
- Pharmacogenetics and Drug Metabolism 114
-
- Biomedical Text Mining and Ontologies 23
- Co-authors
- Russ B. Altman (140 shared papers)Michelle Whirl‐Carrillo (83 shared papers)Katrin Sangkuhl (57 shared papers)Caroline F. Thorn (41 shared papers)Li Gong (34 shared papers)Andrea Gaedigk (38 shared papers)Kelly E. Caudle (38 shared papers)MV Relling (1 shared paper)
- Journals
- Pharmacogenetics and Genomics (90 papers)Clinical Pharmacology & Therapeutics (83 papers)Genetics in Medicine (9 papers)Biopolymers (5 papers)Journal of Medicinal Chemistry (4 papers)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Teri E. Klein
346 papers receiving 30.0k citations
Teri E. Klein's Hit Papers
Peers
Comparison fields: 5 of 191
- Pharmacology 11.9k
- Transplantation 777
- Pediatrics, Perinatology and Child Health 4.9k
- Pharmacology 2.9k
- Genetics 4.5k
Countries citing papers authored by Teri E. Klein
This map shows the geographic impact of Teri E. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teri E. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teri E. Klein more than expected).
Fields of papers citing papers by Teri E. Klein
This network shows the impact of papers produced by Teri E. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teri E. Klein. The network helps show where Teri E. Klein may publish in the future.
Co-authors
The 25 scholars most cited alongside Teri E. Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 361 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacogenomics Knowledge for Personalized Medicine Hit paper breakdown → | 2012 | 1329 |
| 2 | Doxorubicin pathways Hit paper breakdown → | 2010 | 1318 |
| 3 | Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data Hit paper breakdown → | 2009 | 1105 |
| 4 | Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics Hit paper breakdown → | 2016 | 1039 |
| 5 | CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network Hit paper breakdown → | 2011 | 788 |
| 6 | Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update Hit paper breakdown → | 2013 | 690 |
| 7 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors Hit paper breakdown → | 2015 | 678 |
| 8 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing Hit paper breakdown → | 2015 | 512 |
| 9 | Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing Hit paper breakdown → | 2011 | 474 |
| 10 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update Hit paper breakdown → | 2017 | 458 |
| 11 | Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update Hit paper breakdown → | 2016 | 458 |
| 12 | Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update Hit paper breakdown → | 2014 | 455 |
| 13 | An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine Hit paper breakdown → | 2021 | 441 |
| 14 | Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on Hit paper breakdown → | 2018 | 426 |
| 15 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update Hit paper breakdown → | 2017 | 422 |
| 16 | Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing Hit paper breakdown → | 2011 | 406 |
| 17 | Metformin pathways Hit paper breakdown → | 2012 | 387 |
| 18 | Standardizing Hit paper breakdown → | 2019 | 386 |
| 19 | Prediction of CYP2D6 phenotype from genotype across world populations Hit paper breakdown → | 2016 | 365 |
| 20 | 2011 | 364 |
About Teri E. Klein
Teri E. Klein is a scholar working on Pharmacology, Molecular Biology, Genetics, Pediatrics, Perinatology and Child Health and Oncology, having authored 361 papers that have together received 30.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (114 papers), Genomics and Rare Diseases (44 papers), Pharmaceutical studies and practices (31 papers), Biomedical Text Mining and Ontologies (23 papers), Folate and B Vitamins Research (20 papers), Drug Transport and Resistance Mechanisms (20 papers), Computational Drug Discovery Methods (20 papers) and Collagen: Extraction and Characterization (14 papers). The work is most often cited by research in Pharmacology (11.9k citations), Transplantation (777 citations), Pediatrics, Perinatology and Child Health (4.9k citations), Pharmacology (2.9k citations) and Genetics (4.5k citations). Teri E. Klein has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Russ B. Altman, Michelle Whirl‐Carrillo, Katrin Sangkuhl, Caroline F. Thorn, Li Gong, Andrea Gaedigk, Kelly E. Caudle, MV Relling, Howard L. McLeod and Stuart A. Scott. Their work appears in journals such as Pharmacogenetics and Genomics, Clinical Pharmacology & Therapeutics, Genetics in Medicine, Biopolymers and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.